Smith & Nephew appoints Non-Executive Director 10 July 2008 Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, announces the appointment of an additional Non-Executive Director to the Board. Joseph C. Papa, aged 52, and based in Michigan is Chairman of Perrigo Company. Perrigo is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients and consumer products. Joe has considerable experience in sales and marketing and has held senior management positions with Cardinal Health, Watson Pharmaceuticals, G.D. Searle and Novartis. Joe will join the Board on 1 August 2008. He has no details to disclose under paragraph 9.6.13 (2) to 9.6.13 (6) of The Listing Rules. John Buchanan, Chairman of Smith & Nephew, said today: "We are delighted that Joe has agreed to join the Board. He will bring additional international experience in the medical technology industry. We are looking forward to working with him." Enquiries Investors Liz Hewitt Tel: +44 (0)20 7401 7646 Smith & Nephew Group Director Corporate Affairs Media Jon Coles Tel: +44 (0)20 7404 5959 Brunswick - London About Smith & Nephew Smith & Nephew is a global medical technology business, specialising in Orthopaedic Reconstruction, Orthopaedic Trauma and Clinical Therapies, Endoscopy and Advanced Wound Management products. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies. Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2007 were USD3.4 billion. About Perrigo Company Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products. The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The Company's primary markets and locations of manufacturing facilities are the United States, Israel, Mexico and the United Kingdom. Visit Perrigo on the Internet (http://www.perrigo.com). This information is provided by RNS The company news service from the London Stock Exchange END
Contact Information: Contacts: RNS Customer Services 0044-207797-4400 http://www.rns.com